Skip to main content

Pneumococcal 20-valent conjugate vaccine Disease Interactions

There is 1 disease interaction with pneumococcal 20-valent conjugate vaccine.

Moderate

Pneumococcal 20-valent (applies to pneumococcal 20-valent conjugate vaccine) Immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

Safety and immunogenicity data on pneumococcal 20 valent conjugate vaccine are not available for immunocompromised groups and vaccination should be considered on an individual basis. Based on experience with pneumococcal vaccines, patients with altered immunocompetence may have a reduced immune response to this vaccine.

References

  1. (2022) "Product Information. Prevenar-20 (pneumococcal 20-valent conjugate vaccine)." Pfizer Australia Pty Ltd, pfpprvni11222

Pneumococcal 20-valent conjugate vaccine drug interactions

There are 290 drug interactions with pneumococcal 20-valent conjugate vaccine.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer